Retractable Technologies, Inc. (NYSE:RVP) CEO Thomas J. Shaw Acquires 29,112 Shares of Stock

Retractable Technologies, Inc. (NYSE:RVP) CEO Thomas J. Shaw purchased 29,112 shares of Retractable Technologies stock in a transaction dated Wednesday, January 22nd. The stock was bought at an average cost of $0.78 per share, with a total value of $22,707.36. Following the completion of the transaction, the chief executive officer now directly owns 15,006,863 shares of the company’s stock, valued at $11,705,353.14. This represents a 0.19 % increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.

Retractable Technologies Stock Up 3.5 %

NYSE RVP opened at $0.79 on Friday. Retractable Technologies, Inc. has a 1-year low of $0.56 and a 1-year high of $1.34. The company has a quick ratio of 5.92, a current ratio of 8.57 and a debt-to-equity ratio of 0.01. The firm’s fifty day simple moving average is $0.67 and its 200-day simple moving average is $0.83.

Wall Street Analysts Forecast Growth

Separately, StockNews.com assumed coverage on shares of Retractable Technologies in a research note on Wednesday. They issued a “hold” rating on the stock.

Institutional Investors Weigh In On Retractable Technologies

An institutional investor recently bought a new position in Retractable Technologies stock. PFG Investments LLC acquired a new position in Retractable Technologies, Inc. (NYSE:RVP) during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 34,600 shares of the company’s stock, valued at approximately $27,000. PFG Investments LLC owned about 0.12% of Retractable Technologies as of its most recent filing with the Securities and Exchange Commission (SEC). 7.58% of the stock is currently owned by institutional investors.

About Retractable Technologies

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.